Interleukin 9 mediates T follicular helper cell activation to promote antibody responses.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Lausanne : Frontiers Research Foundation]
    • Subject Terms:
    • Abstract:
      Antigen-specific humoral responses are orchestrated through complex interactions among immune cells in lymphoid tissues, including the collaboration between B cells and T follicular helper (Tfh) cells. Accumulating evidence indicates a crucial role for interleukin-9 (IL-9) in the formation of germinal centers (GCs), enhancing the generation of class-switched high-affinity antibodies. However, the exact function of IL-9 in Tfh cell regulation remains unclear. In this study, we examined the humoral immune responses of CD4 Cre/+ Il9ra fl/fl mice, which lack an IL-9-specific receptor in Tfh cells. Upon intraperitoneal immunization with sheep red blood cells (SRBCs), CD4 Cre/+ Il9ra fl/fl mice displayed diminished levels of SRBC-specific IgG antibodies in their sera, along with reduced levels of GC B cells and plasma cells. Notably, Il9ra-deficient Tfh cells in the spleen exhibited decreased expression of their signature molecules such as B-cell lymphoma 6, C-X-C chemokine receptor 5, IL-4, and IL-21 compared to control mice. In models of allergic asthma induced by house dust mite (HDM) inhalation, CD4 Cre/+ Il9ra fl/fl mice failed to elevate serum levels of HDM-specific IgE and IgG. This was accompanied by reductions in Tfh cells, GC B cells, and plasma cells in mediastinal lymph nodes. Furthermore, group 2 innate lymphoid cells (ILC2s) were identified as producers of IL-9 under immunizing conditions, possibly induced by leukotrienes released by activated IgD + B cells around the T-B border. These observations may indicate the critical role of IL-9 receptor signaling in the activation of Tfh cells, with ILC2s potentially capable of supplying IL-9 in organized lymphoid tissues.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
      (Copyright © 2024 Sato, Ikegami, Yanagi, Ohyu, Sugaya, Shirato, Tanemoto, Kamiya, Kikuchi, Kamada, Nakata, Kamekura, Sato, Takano, Miyajima, Watanabe and Ichimiya.)
    • References:
      Allergy. 2014 Oct;69(10):1300-7. (PMID: 24939388)
      Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):E488-97. (PMID: 21808017)
      Immunity. 2014 Aug 21;41(2):283-95. (PMID: 25088770)
      Nat Rev Immunol. 2015 May;15(5):271-82. (PMID: 25882242)
      Curr Opin Immunol. 2024 Apr;87:102421. (PMID: 38733669)
      Science. 2009 Aug 21;325(5943):1006-10. (PMID: 19608860)
      Nat Immunol. 2011 Oct 09;12(11):1071-7. (PMID: 21983833)
      Trends Immunol. 2021 Jun;42(6):536-550. (PMID: 33972167)
      Immunity. 2018 Aug 21;49(2):264-274.e4. (PMID: 30076099)
      J Exp Med. 2015 Feb 9;212(2):217-33. (PMID: 25646266)
      J Exp Med. 2000 Dec 4;192(11):1545-52. (PMID: 11104797)
      Nat Immunol. 2022 Aug;23(8):1157-1168. (PMID: 35817844)
      Immunity. 2018 Jun 19;48(6):1195-1207.e6. (PMID: 29907525)
      J Exp Med. 2014 Jun 30;211(7):1297-305. (PMID: 24913235)
      Commun Biol. 2024 Feb 15;7(1):185. (PMID: 38360857)
      Nat Immunol. 2020 Jul;21(7):777-789. (PMID: 32572238)
      J Allergy Clin Immunol. 2021 May;147(5):1531-1547. (PMID: 33965091)
      Nat Rev Immunol. 2021 Jan;21(1):37-48. (PMID: 32788707)
      Semin Immunopathol. 2017 Jan;39(1):69-77. (PMID: 27909880)
      BMC Immunol. 2009 Jan 09;10:2. (PMID: 19134178)
      Nat Immunol. 2018 Sep;19(9):1025-1034. (PMID: 30082831)
      Immunol Rev. 2018 Nov;286(1):37-52. (PMID: 30294963)
      J Invest Dermatol. 2014 Jul;134(7):1903-1911. (PMID: 24487305)
      Front Immunol. 2019 Feb 13;10:217. (PMID: 30828332)
      Commun Biol. 2021 May 12;4(1):563. (PMID: 33980982)
      Nat Immunol. 2016 Oct;17(10):1197-1205. (PMID: 27573866)
      Immunity. 2020 Dec 15;53(6):1136-1150. (PMID: 33326765)
      Signal Transduct Target Ther. 2021 Feb 26;6(1):94. (PMID: 33637672)
      Science. 2017 May 19;356(6339):. (PMID: 28408722)
      J Exp Med. 2022 Jan 3;219(1):. (PMID: 34792530)
      Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11792-7. (PMID: 25071203)
      J Exp Med. 2023 Oct 2;220(10):. (PMID: 37466652)
      Nat Commun. 2015 Jan 09;6:5862. (PMID: 25575242)
      Front Immunol. 2019 Jan 07;9:3079. (PMID: 30666254)
      Eur J Immunol. 1993 Jul;23(7):1687-92. (PMID: 7686859)
      Front Immunol. 2021 Oct 25;12:757967. (PMID: 34759931)
      Eur J Immunol. 2011 Aug;41(8):2197-206. (PMID: 21674475)
      Immunity. 2019 May 21;50(5):1132-1148. (PMID: 31117010)
      J Allergy Clin Immunol. 2007 Nov;120(5):1208-15. (PMID: 17919707)
      Am J Pathol. 2011 Jan;178(1):222-32. (PMID: 21224059)
      J Invest Dermatol. 2022 Dec;142(12):3222-3231.e5. (PMID: 35850207)
      Methods Mol Biol. 2017;1585:37-50. (PMID: 28477185)
      J Immunol. 2023 Jul 1;211(1):7-14. (PMID: 37339404)
      Allergy. 2019 Apr;74(4):650-662. (PMID: 30220084)
      Nat Immunol. 2017 Aug;18(8):921-930. (PMID: 28650481)
      J Immunol. 2014 Mar 1;192(5):2442-8. (PMID: 24470502)
      Science. 2018 Jan 5;359(6371):114-119. (PMID: 29302015)
      J Exp Med. 2013 Dec 16;210(13):2951-65. (PMID: 24249111)
      Nat Immunol. 2019 Oct;20(10):1360-1371. (PMID: 31477921)
    • Contributed Indexing:
      Keywords: IL-9; ILC2; T follicular helper cells; follicular mantle zone B cells; germinal center response; leukotrienes
    • Accession Number:
      0 (Interleukin-9)
      0 (Immunoglobulin G)
    • Publication Date:
      Date Created: 20241015 Date Completed: 20241015 Latest Revision: 20241016
    • Publication Date:
      20241016
    • Accession Number:
      PMC11471543
    • Accession Number:
      10.3389/fimmu.2024.1441407
    • Accession Number:
      39403384